Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2005

01-05-2005

Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program

Authors: Jan F. Nygård, Mari Nygård, Gry B. Skare, Steinar Ø. Thoresen

Published in: Cancer Causes & Control | Issue 4/2005

Login to get access
Metadata
Title
Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program
Authors
Jan F. Nygård
Mari Nygård
Gry B. Skare
Steinar Ø. Thoresen
Publication date
01-05-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-004-6295-z

Other articles of this Issue 4/2005

Cancer Causes & Control 4/2005 Go to the issue

OriginalPaper

Previous pregnancy outcome and breast density (United States)

OriginalPaper

Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem

OriginalPaper

A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States)

OriginalPaper

Tobacco use and non-Hodgkin lymphoma: results from a population-based case–control study in the San Francisco Bay Area, California

OriginalPaper

The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States)

OriginalPaper

The Healthy People 2010 smoking prevalence and tobacco control objectives: results from the SimSmoke tobacco control policy simulation model (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits